You are here

Vaccines

Primary tabs

Information on vaccines to counter Ebola and other diseases

The Mission of this group is to follow the development of vaccines and other medications to counter Ebola and other diseases.

Members

Kathy Gilbeaux mdmcdonald MDMcDonald_me_com mike kraft

Email address for group

vaccines_global@m.resiliencesystem.org

U.S. exceeds 400,000 coronavirus deaths

(Reuters) - The U.S. coronavirus death toll topped 400,000 on Tuesday, according to a Reuters tally, as the country hardest hit by the pandemic struggled to meet the demand for vaccines to stem the spread of infection.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Three questions and the emerging answers about COVID-19 Vaccine protection--NPR

As the COVID-19 vaccine rolls out, three big questions loom. First, can someone who has been vaccinated still spread the disease? Second, will the vaccine remain effective as the virus itself evolves? And third, how long will the vaccine's protection last?

Answers to these questions lie in our immune systems. And the answers aren't straightforward because our immune systems are both remarkably adept and remarkably challenging to predict.

...the first question, about whether people who are vaccinated can still spread the disease. Marion Pepper, an immunologist at the University of Washington, says that's not just an open question for this vaccine, but for vaccines in general.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

EU kicks off debate on vaccine travel certificates

BRUSSELS (Reuters) - European Union countries kicked off a debate on Monday on whether people who have received a COVID-19 vaccine should have greater freedom to travel in the summer than those not immunized.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

A new COVID-19 challenge: Mutations rise along with cases

The race against the virus that causes COVID-19 has taken a new turn: Mutations are rapidly popping up, and the longer it takes to vaccinate people, the more likely it is that a variant that can elude current tests, treatments and vaccines could emerge.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Israeli hospital: 98% of staff who got 2nd shot have high-level COVID antibodies

A new serological study conducted at Sheba Medical Center in Ramat Gan has shown 98% of hospital workers who received the second dose of the coronavirus vaccine have developed a high level of antibodies to fight off the virus.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

howdy folks
Page loaded in 0.826 seconds.